Beyond the Expiry Date — Shielding Pharma Supply Chains from Currency Shocks

A medicine sitting on a warehouse shelf in Cairo has a short window. If the Egyptian pound falls sharply against the dollar — as it did more than once between 2022 and 2024 — the price of importing that medicine jumps overnight. The shelf life printed on the box does not care about exchange rates. The hospital budget does. This is the quiet crisis inside MENA's pharmaceutical supply chains. It is not dramatic enough for front-page news, but it costs hundreds of millions of dollars every year, creates drug shortages, and forces patients to go without treatment. The answer is not a new molecule or a new factory. It is better data, read faster, by people who understand what it means. That is what macro-driven business intelligence — BI built on real economic signals — is starting to deliver across the region. A currency is not just a number on a screen. In pharma, it is the invisible expiry date that nobody prints on the label — the one that kills a business before the pills go bad. The C